ZymoGenetics, Inc. (NASDAQ:ZGEN.DL)

CAPS Rating: No stars

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Recs

0
Player Avatar aldebaranccs (< 20) Submitted: 6/11/2010 3:49:56 PM : Outperform Start Price: $4.53 ZGEN.DL Score: +108.72

bull

Report this Post Reply

Featured Broker Partners


Advertisement